BIONANO GENOMICS INC (BNGO)

Company Profile

Bionano Genomics Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in San Diego, California and currently employs 405 full-time employees. The company went IPO on 2018-08-01. Bionano Genomics, Inc. is a genomics company, which provides optical genome mapping (OGM) for genome analysis. The firm offers diagnostic services to physicians specializing in medical management for individuals with genetic conditions, such as pediatric neurodevelopmental disorders, including autism spectrum disorders. The company markets and sells the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation. Its Lineagen business provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, it offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view.

Company Info

BIONANO GENOMICS INC

9640 Towne Centre Drive, 9640 Towne Centre Drive

San Diego CALIFORNIA 92121

P: 18588887600

CEO: R. Erik Holmlin

Employees: 405

Website: https://bionano.com/